Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-08 5:02 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cedars Sinai Intellectual Property Co | 4,001,132 8.42% | -865,000 (-17.78%) | View |
| 2023-02-16 6:07 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cedars Sinai Intellectual Property Co | 4,866,132 10.5% | -142,376 (-2.84%) | View |
| 2023-02-14 4:27 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Point72 Asset Management L.P. | 3,114,107 6.7% | 1,131,546 (+57.07%) | View |
| 2023-02-14 3:01 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cormorant Asset Management LP | 2,090,000 4.5% | -134,847 (-6.06%) | View |
| 2023-02-14 2:35 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | PERCEPTIVE ADVISORS LLC | 1,212,694 2.6% | -1,960,091 (-61.78%) | View |
| 2023-02-14 1:58 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | EVENTIDE ASSET MANAGEMENT LLC | 1,032,938 2.2% | -2,709,569 (-72.40%) | View |
| 2023-02-14 10:06 am Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | RTW INVESTMENTS LP | 3,354,303 7.2% | 90,272 (+2.77%) | View |
| 2023-02-03 12:09 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | BlackRock Inc. BLK | 2,807,704 6.1% | 918,944 (+48.65%) | View |
| 2022-06-06 5:50 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cormorant Asset Management LP | 2,224,847 5.68% | 376,825 (+20.39%) | View |
| 2022-05-09 3:23 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | BlackRock Inc. BLK | 1,888,760 4.8% | -272,009 (-12.59%) | View |
| 2022-02-14 4:48 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | PERCEPTIVE ADVISORS LLC | 3,172,785 8.1% | -141,247 (-4.26%) | View |
| 2022-02-14 4:35 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Point72 Asset Management L.P. | 1,982,561 5.1% | -665,463 (-25.13%) | View |
| 2022-02-14 3:15 pm Sale | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cormorant Asset Management LP | 1,848,022 4.75% | -250,000 (-11.92%) | View |
| 2022-02-14 11:35 am Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | EVENTIDE ASSET MANAGEMENT LLC | 3,742,507 9.6% | 3,742,507 (New Position) | View |
| 2022-02-14 10:20 am Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Nestle Health Science US Holdings Inc. | 3,730,841 9.58% | 3,730,841 (New Position) | View |
| 2022-02-11 12:47 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cedars Sinai Intellectual Property Co | 5,008,508 12.8% | 5,008,508 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | BlackRock Inc. BLK | 2,160,769 5.5% | 2,160,769 (New Position) | View |
| 2021-03-26 4:06 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cormorant Asset Management LP | 2,098,022 5.41% | 2,098,022 (New Position) | View |
| 2021-03-22 5:02 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Point72 Asset Management L.P. | 2,648,024 6.8% | 2,648,024 (New Position) | View |
| 2021-03-18 09:14 am Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | PERCEPTIVE ADVISORS LLC | 3,314,032 8.6% | 3,314,032 (New Position) | View |